4-tert-Butyl-1,3,5-triazin-2-amine | 114640-81-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: 4-tert-Butyl-1,3,5-triazin-2-amine
• CAS: 114640-81-2
• 化学式: C₇H₁₂N₄
• 分子量: 152.2
• InChiKey: TWPBHKXORSEQMM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  64.7
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• [EN] MITOCHONDRIAL PH PROBE<br/>[FR] SONDE DE PH MITOCHONDRIAL
  申请人：ECOLE POLYTECHNIQUE FED LAUSANNE EPFL

  公开号：WO2019180105A1

  公开（公告）日：2019-09-26

  The present invention relates to dual fluorophore ratiometric mitochondrial pH probes, their uses and their manufacture.

  本发明涉及双荧光比率线粒体pH探针，以及它们的用途和制造方法。
• IMIDAZOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE
  申请人：Lai Yingjie

  公开号：US20130096104A1

  公开（公告）日：2013-04-18

  The invention provides compounds of Formulas Ia-Ib, stereoisomers or pharmaceutically acceptable salts thereof, wherein A, X, R 1 , R 2 , R 4 , R 5 and R 16 are defined herein, a pharmaceutical composition that includes a compound of Formulas Ia-Ib and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of using the compound or composition in therapy, as an inhibitor of TYK2 kinase and conditions related, such as inflammatory illnesses, inflammatory bowel disease or psoriasis.

  本发明提供了公式Ia-Ib的化合物、立体异构体或其药学上可接受的盐，其中A、X、R1、R2、R4、R5和R16在此定义，一种包括公式Ia-Ib化合物和药学上可接受的载体、佐剂或车载物的药物组合物，以及使用该化合物或组合物作为TYK2激酶的抑制剂和相关疾病的治疗方法，例如炎症性疾病、炎症性肠病或牛皮癣。
• NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS
  申请人：HUTCHISON MEDIPHARMA LIMITED

  公开号：US20150291593A1

  公开（公告）日：2015-10-15

  Provided are novel heteroaryl and heterocycle compounds of formula (I-1), (I-2) or (I-3) and pharmaceutical compositions comprising them, uses and methods thereof for inhibiting the activity of PI 3 K and for treating inflammatory and autoimmune disorders diseases and cancer.

  提供的是式(I-1)、(I-2)或(I-3)的新型杂环和杂环芳基化合物，以及包含它们的药物组合物、使用方法和方法，用于抑制PI3K活性和治疗炎症、自身免疫性疾病和癌症。
• NOVEL HETEROARYL AND HETEROCYCLE COMPOUNDS, COMPOSITIONS AND METHODS THEREOF
  申请人：HUTCHISON MEDIPHARMA LIMITED

  公开号：US20150307520A1

  公开（公告）日：2015-10-29

  Disclosed are novel heteroaryl and heterocycle compounds of formula I-1, I-2 or I-3 and pharmaceutical compositions comprising them, uses and methods thereof for inhibiting the activity of PI 3 K and for treating inflammatory and autoimmune diseases and cancer.

  本发明涉及一种新型的杂环和杂环烷基化合物，其化学式为I-1、I-2或I-3，以及包含它们的制药组合物、用途和方法，用于抑制PI3K的活性和治疗炎症、自身免疫性疾病和癌症。
• PRMT5 INHIBITOR COMPOUNDS
  申请人：University of Florida Research Foundation, Incorporated

  公开号：US20220185792A1

  公开（公告）日：2022-06-16

  A series of PRMT5 inhibitor compounds are described. The compounds are useful as PRMT5 inhibitor compounds and in the treatment of PRMT5 mediated diseases, disorders, and symptoms thereof.